[
  {
    "ts": null,
    "headline": "NEW YORK MARKET CLOSE: Shares climb as Greenland tension abates",
    "summary": "NEW YORK MARKET CLOSE: Shares climb as Greenland tension abates",
    "url": "https://finnhub.io/api/news?id=252cc39e9416d7d8f10c28a0a46135df3452fbf1f7dfffcb54ba65e7c3550a48",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769117100,
      "headline": "NEW YORK MARKET CLOSE: Shares climb as Greenland tension abates",
      "id": 138211873,
      "image": "",
      "related": "ABT",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=252cc39e9416d7d8f10c28a0a46135df3452fbf1f7dfffcb54ba65e7c3550a48"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Forecasts Lower Q1 Profit as Nutrition Discounts Hit Results",
    "summary": "Abbott guided first-quarter earnings below expectations after promotions weighed on nutrition sales and margins.",
    "url": "https://finnhub.io/api/news?id=73062fbefa21e1f37f4db547a055f4f8630b2d81383a2030de7094f1e717adac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769110426,
      "headline": "Abbott Forecasts Lower Q1 Profit as Nutrition Discounts Hit Results",
      "id": 138206899,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott guided first-quarter earnings below expectations after promotions weighed on nutrition sales and margins.",
      "url": "https://finnhub.io/api/news?id=73062fbefa21e1f37f4db547a055f4f8630b2d81383a2030de7094f1e717adac"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories Raised Prices, Prompting Sales Slump",
    "summary": "The medical-products maker’s shares tumbled after its quarterly profit and sales underwhelmed investors.",
    "url": "https://finnhub.io/api/news?id=77c3179418a7f8d71ebb6bceedecf0a01ef472dece07f8892cf1c389d357b08f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769110260,
      "headline": "Abbott Laboratories Raised Prices, Prompting Sales Slump",
      "id": 138206900,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The medical-products maker’s shares tumbled after its quarterly profit and sales underwhelmed investors.",
      "url": "https://finnhub.io/api/news?id=77c3179418a7f8d71ebb6bceedecf0a01ef472dece07f8892cf1c389d357b08f"
    }
  },
  {
    "ts": null,
    "headline": "Equities Rise Intraday as Markets Parse Data, Earnings; Precious Metals Jump",
    "summary": "US benchmark equity indexes were higher intraday as traders assessed the latest economic data and co",
    "url": "https://finnhub.io/api/news?id=f598ef8c6942f5c9c797aa2c373079b6c60320ba0b77adcb6b81e77fae369d1a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769108760,
      "headline": "Equities Rise Intraday as Markets Parse Data, Earnings; Precious Metals Jump",
      "id": 138206867,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes were higher intraday as traders assessed the latest economic data and co",
      "url": "https://finnhub.io/api/news?id=f598ef8c6942f5c9c797aa2c373079b6c60320ba0b77adcb6b81e77fae369d1a"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Rise in Afternoon Trading",
    "summary": "Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index and the State Street",
    "url": "https://finnhub.io/api/news?id=1d110ad0f2c2b34c6c0fa7be88c07a4247c600e7cbfac732b7afc1fa1c595fe3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769107877,
      "headline": "Sector Update: Health Care Stocks Rise in Afternoon Trading",
      "id": 138206902,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index and the State Street",
      "url": "https://finnhub.io/api/news?id=1d110ad0f2c2b34c6c0fa7be88c07a4247c600e7cbfac732b7afc1fa1c595fe3"
    }
  },
  {
    "ts": null,
    "headline": "Biosensors Market Forecast 2025-2033: Total Revenues to Exceed $75.84 Billion by 2033 | Astute Analytica",
    "summary": "The global biosensors market is driven by rapid adoption in healthcare, biopharma, environmental monitoring, and industrial applications. Rising chronic disease prevalence, point-of-care diagnostics, wearable and embedded devices, and IoT integration are accelerating market growth, while technological advances in electrochemical, optical, and graphene-based sensors enhance precision, efficiency, and accessibility.Chicago, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The global biosensors market was valued",
    "url": "https://finnhub.io/api/news?id=ec4c9bbe8254fdae3062a7cf87b9adc9e427ae334835f441914483b40e76318c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769105640,
      "headline": "Biosensors Market Forecast 2025-2033: Total Revenues to Exceed $75.84 Billion by 2033 | Astute Analytica",
      "id": 138206903,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The global biosensors market is driven by rapid adoption in healthcare, biopharma, environmental monitoring, and industrial applications. Rising chronic disease prevalence, point-of-care diagnostics, wearable and embedded devices, and IoT integration are accelerating market growth, while technological advances in electrochemical, optical, and graphene-based sensors enhance precision, efficiency, and accessibility.Chicago, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The global biosensors market was valued",
      "url": "https://finnhub.io/api/news?id=ec4c9bbe8254fdae3062a7cf87b9adc9e427ae334835f441914483b40e76318c"
    }
  },
  {
    "ts": null,
    "headline": "Abbott’s stock falls by nearly 11% following Q4 sales miss",
    "summary": "Abbott missed analysts’ profit expectations for Q4 2025, yet the company’s full year financials were buoyed by strong performance in its medtech portfolio.",
    "url": "https://finnhub.io/api/news?id=5d3f35014913e07353509f5ebc332c56954e1b2524b6849b5d078b3d3e07357e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769105397,
      "headline": "Abbott’s stock falls by nearly 11% following Q4 sales miss",
      "id": 138206904,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott missed analysts’ profit expectations for Q4 2025, yet the company’s full year financials were buoyed by strong performance in its medtech portfolio.",
      "url": "https://finnhub.io/api/news?id=5d3f35014913e07353509f5ebc332c56954e1b2524b6849b5d078b3d3e07357e"
    }
  },
  {
    "ts": null,
    "headline": "Why Abbott Laboratories (ABT) Shares Are Sliding Today",
    "summary": "Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.3% in the afternoon session after the company reported fourth-quarter revenue that missed Wall Street's expectations.",
    "url": "https://finnhub.io/api/news?id=f560fb405e9b32b2c8e0c2e1e261aa507f1833859e8e12696a5cb0876ebe34ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769104588,
      "headline": "Why Abbott Laboratories (ABT) Shares Are Sliding Today",
      "id": 138206905,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.3% in the afternoon session after the company reported fourth-quarter revenue that missed Wall Street's expectations.",
      "url": "https://finnhub.io/api/news?id=f560fb405e9b32b2c8e0c2e1e261aa507f1833859e8e12696a5cb0876ebe34ce"
    }
  },
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Gains 450 Points; Corning Rallies But Celestica, Abbott Crushed (Live Coverage)",
    "summary": "The Dow Jones index rose Thursday on surprise GDP data. Nvidia and Tesla rallied in morning trading.",
    "url": "https://finnhub.io/api/news?id=f338e6cc65270f715965f1aa9bd02da7996daf52943fd4189091f43f6aed1759",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769103087,
      "headline": "Stock Market Today: Dow Gains 450 Points; Corning Rallies But Celestica, Abbott Crushed (Live Coverage)",
      "id": 138205703,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The Dow Jones index rose Thursday on surprise GDP data. Nvidia and Tesla rallied in morning trading.",
      "url": "https://finnhub.io/api/news?id=f338e6cc65270f715965f1aa9bd02da7996daf52943fd4189091f43f6aed1759"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories Q4 Earnings Call Highlights",
    "summary": "Abbott Laboratories (NYSE:ABT) detailed fourth-quarter 2025 results and outlined its 2026 outlook on its earnings conference call, emphasizing continued momentum in medical devices, a transition plan to restart volume growth in nutrition, and an expected acceleration in diagnostics as several prior-",
    "url": "https://finnhub.io/api/news?id=abb267f034b280175fa84e89aaeec4d6b88e34b949da40e1261ffd55684feb0d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769101667,
      "headline": "Abbott Laboratories Q4 Earnings Call Highlights",
      "id": 138205853,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) detailed fourth-quarter 2025 results and outlined its 2026 outlook on its earnings conference call, emphasizing continued momentum in medical devices, a transition plan to restart volume growth in nutrition, and an expected acceleration in diagnostics as several prior-",
      "url": "https://finnhub.io/api/news?id=abb267f034b280175fa84e89aaeec4d6b88e34b949da40e1261ffd55684feb0d"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Abbott Shares Fall After Q4 Revenue Miss; GE Shares Down Despite EPS, Revenue Beat",
    "summary": "All three major US stock indexes were up in late-morning trading Thursday, as geopolitical tensions",
    "url": "https://finnhub.io/api/news?id=d1aa3dd79ae5aa00841981052e7e89a572bcb51f7454b46ce99c4822da441433",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769099158,
      "headline": "Top Midday Stories: Abbott Shares Fall After Q4 Revenue Miss; GE Shares Down Despite EPS, Revenue Beat",
      "id": 138205804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were up in late-morning trading Thursday, as geopolitical tensions",
      "url": "https://finnhub.io/api/news?id=d1aa3dd79ae5aa00841981052e7e89a572bcb51f7454b46ce99c4822da441433"
    }
  },
  {
    "ts": null,
    "headline": "Jobless Claims Come in Slightly Higher",
    "summary": "Jobless Claims Come in Slightly Higher.",
    "url": "https://finnhub.io/api/news?id=3afa4028a398fac753597492fbd273fabcdf3c9455ce405d8d217a4db0cd5077",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769097960,
      "headline": "Jobless Claims Come in Slightly Higher",
      "id": 138205805,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Jobless Claims Come in Slightly Higher.",
      "url": "https://finnhub.io/api/news?id=3afa4028a398fac753597492fbd273fabcdf3c9455ce405d8d217a4db0cd5077"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Q4 2025 Earnings Call Transcript",
    "summary": "Mike Comilla: With me today are Robert Ford, Chairman and Chief Executive Officer, and Philip Boudreau, Executive Vice President, Finance and Chief Financial Officer.  Abbott Laboratories cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.  Economic, competitive, governmental, technological, and other factors that may affect Abbott Laboratories' operations are discussed in item one a Risk Factors, to our annual report on Form 10-Ks for the year ended 12/31/2024.",
    "url": "https://finnhub.io/api/news?id=0911c7015f9de99ba1b6c5503ee55845e2f2c0cd81ae576254455e114e2b7d4c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769096317,
      "headline": "Abbott (ABT) Q4 2025 Earnings Call Transcript",
      "id": 138204652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Mike Comilla: With me today are Robert Ford, Chairman and Chief Executive Officer, and Philip Boudreau, Executive Vice President, Finance and Chief Financial Officer.  Abbott Laboratories cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.  Economic, competitive, governmental, technological, and other factors that may affect Abbott Laboratories' operations are discussed in item one a Risk Factors, to our annual report on Form 10-Ks for the year ended 12/31/2024.",
      "url": "https://finnhub.io/api/news?id=0911c7015f9de99ba1b6c5503ee55845e2f2c0cd81ae576254455e114e2b7d4c"
    }
  },
  {
    "ts": null,
    "headline": "Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%",
    "summary": "Weekly Jobless Claims continue to portray a labor market cruising along at a healthy low rate of unemployment claims.",
    "url": "https://finnhub.io/api/news?id=8a6c63f9e896b1891115a5c9e405f04f4203bdd741eb4b10f3f28b91d459820a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769095740,
      "headline": "Jobless Claims Stay Low at +200K, Q3 GDP Up to +4.4%",
      "id": 138205807,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Weekly Jobless Claims continue to portray a labor market cruising along at a healthy low rate of unemployment claims.",
      "url": "https://finnhub.io/api/news?id=8a6c63f9e896b1891115a5c9e405f04f4203bdd741eb4b10f3f28b91d459820a"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes",
    "summary": "Abbott Laboratories stock fell Thursday after the medical-products maker reporting disappointing results, hit by a slump in the division that makes baby formula and nutrition shakes. Fourth-quarter sales in the nutrition business, which includes Similac baby formula and Ensure drinks, dropped 8.",
    "url": "https://finnhub.io/api/news?id=0c063ace3043bf0eed1fa0e140e474b7afbbc258e9594cf8b2e7a14980849e76",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769095346,
      "headline": "Abbott Stock Drops on Slumping Sales of Baby Formula and Nutrition Shakes",
      "id": 138205857,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories stock fell Thursday after the medical-products maker reporting disappointing results, hit by a slump in the division that makes baby formula and nutrition shakes. Fourth-quarter sales in the nutrition business, which includes Similac baby formula and Ensure drinks, dropped 8.",
      "url": "https://finnhub.io/api/news?id=0c063ace3043bf0eed1fa0e140e474b7afbbc258e9594cf8b2e7a14980849e76"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories First-Quarter Earnings Outlook Misses Street Views; Stock Declines",
    "summary": "Abbott Laboratories (ABT) issued a first-quarter earnings outlook below market estimates on Thursday",
    "url": "https://finnhub.io/api/news?id=a8a16fee9785ecf1417a28c87635a6f9b548520f903abb95947251e9e0af53ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769095317,
      "headline": "Abbott Laboratories First-Quarter Earnings Outlook Misses Street Views; Stock Declines",
      "id": 138204653,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (ABT) issued a first-quarter earnings outlook below market estimates on Thursday",
      "url": "https://finnhub.io/api/news?id=a8a16fee9785ecf1417a28c87635a6f9b548520f903abb95947251e9e0af53ba"
    }
  },
  {
    "ts": null,
    "headline": "Abbott's Q4 Earnings Meet Estimates, Revenues Miss, Stock Falls",
    "summary": "ABT's Q4 earnings meet estimates but revenues miss, sending shares down as strong device growth is offset by weaker nutrition and diagnostics sales.",
    "url": "https://finnhub.io/api/news?id=086b7daa4ce2a83a030b33c64c56da81baf87abcce6b690f7498089e1a5cb164",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769093340,
      "headline": "Abbott's Q4 Earnings Meet Estimates, Revenues Miss, Stock Falls",
      "id": 138205858,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "ABT's Q4 earnings meet estimates but revenues miss, sending shares down as strong device growth is offset by weaker nutrition and diagnostics sales.",
      "url": "https://finnhub.io/api/news?id=086b7daa4ce2a83a030b33c64c56da81baf87abcce6b690f7498089e1a5cb164"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "summary": "While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=7834583defdc624aaf255bd5f788792bbf2077d60d420ada4d703b2079d5a8d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769092206,
      "headline": "Abbott (ABT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates",
      "id": 138205859,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=7834583defdc624aaf255bd5f788792bbf2077d60d420ada4d703b2079d5a8d4"
    }
  },
  {
    "ts": null,
    "headline": "GE Aerospace stock slumps, Abbott falls on Q4 sales, Mobileye's guidance",
    "summary": "Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including GE Aerospace (GE) shares slumping in Thursday's premarket trading, Abbott Laboratories' (ABT) stock reaction to its weak fourth quarter sales results, and Mobileye Global (MBLY) issuing weak guidance amid tariff headwinds for automakers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=3ccc5fd4ae2ae8b37a90f167683e735a13e0ee3e0ccdff919a9bc8efee130914",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769091287,
      "headline": "GE Aerospace stock slumps, Abbott falls on Q4 sales, Mobileye's guidance",
      "id": 138204618,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Morning Brief Host Julie Hyman tracks several of the day's top trending stock tickers, including GE Aerospace (GE) shares slumping in Thursday's premarket trading, Abbott Laboratories' (ABT) stock reaction to its weak fourth quarter sales results, and Mobileye Global (MBLY) issuing weak guidance amid tariff headwinds for automakers. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=3ccc5fd4ae2ae8b37a90f167683e735a13e0ee3e0ccdff919a9bc8efee130914"
    }
  },
  {
    "ts": null,
    "headline": "Wall Street Lunch: Fed's Favorite Inflation Gauge 'Stuck'?",
    "summary": "Rates climb after core PCE holds at 2.8% YoY. GE Aerospace slips as analysts warn margin expansion may slow. EU regulators prepare parallel reviews of rival Warner bids.",
    "url": "https://finnhub.io/api/news?id=57b37fd5239380c7d8cdda872e34f4bc072bec751a1ff20641997f8e3f3217ea",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769091251,
      "headline": "Wall Street Lunch: Fed's Favorite Inflation Gauge 'Stuck'?",
      "id": 138206474,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1388729452/image_1388729452.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Rates climb after core PCE holds at 2.8% YoY. GE Aerospace slips as analysts warn margin expansion may slow. EU regulators prepare parallel reviews of rival Warner bids.",
      "url": "https://finnhub.io/api/news?id=57b37fd5239380c7d8cdda872e34f4bc072bec751a1ff20641997f8e3f3217ea"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.",
    "summary": "Shares of  Abbott Laboratories  tumbled Thursday after the medical devices maker posted fourth-quarter earnings and sales that underwhelmed Wall Street.  The company said it expects full-year adjusted earnings in the range of $5.55 to $5.80 a share.  Abbott also is targeting full-year organic sales growth of between 6.5% to 7.5%.",
    "url": "https://finnhub.io/api/news?id=57e65b9d82ffaf11e0ab7631f7258f25ffb081a22d9b121213c88c42674c3714",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769090760,
      "headline": "Abbott Stock Slumps. The Nutrition Business Is a Drag on Earnings.",
      "id": 138204655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Shares of  Abbott Laboratories  tumbled Thursday after the medical devices maker posted fourth-quarter earnings and sales that underwhelmed Wall Street.  The company said it expects full-year adjusted earnings in the range of $5.55 to $5.80 a share.  Abbott also is targeting full-year organic sales growth of between 6.5% to 7.5%.",
      "url": "https://finnhub.io/api/news?id=57e65b9d82ffaf11e0ab7631f7258f25ffb081a22d9b121213c88c42674c3714"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms",
    "summary": "Abbott stock tumbled Thursday on a disappointing fourth-quarter report as first-quarter guidance also came up short.",
    "url": "https://finnhub.io/api/news?id=8d91e01842d1f8510d125f0ba633678bdc0ae4d50793a482ae038674d7d501ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769089857,
      "headline": "Abbott Tumbles On Disappointing Fourth Quarter As Exact Closing Looms",
      "id": 138203856,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott stock tumbled Thursday on a disappointing fourth-quarter report as first-quarter guidance also came up short.",
      "url": "https://finnhub.io/api/news?id=8d91e01842d1f8510d125f0ba633678bdc0ae4d50793a482ae038674d7d501ea"
    }
  },
  {
    "ts": null,
    "headline": "Hologic Q1 Earnings Preview: How Should You Play the Stock Now?",
    "summary": "HOLX heads into Q1 earnings with rising EPS and revenue estimates, strong segment momentum and a pending buyout limiting near-term upside.",
    "url": "https://finnhub.io/api/news?id=1f877a9ef1c62812f9ba91f0cac178298d18106db614abb4f103d7a629a21e90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769089800,
      "headline": "Hologic Q1 Earnings Preview: How Should You Play the Stock Now?",
      "id": 138204656,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "HOLX heads into Q1 earnings with rising EPS and revenue estimates, strong segment momentum and a pending buyout limiting near-term upside.",
      "url": "https://finnhub.io/api/news?id=1f877a9ef1c62812f9ba91f0cac178298d18106db614abb4f103d7a629a21e90"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Matches Q4 Earnings Estimates",
    "summary": "Abbott (ABT) delivered earnings and revenue surprises of +0.20% and -2.76%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=30efadb4b98eeeb4ea73139a9099c6d50c0cb7b1bd1146804e6b64b2ce3840e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769089202,
      "headline": "Abbott (ABT) Matches Q4 Earnings Estimates",
      "id": 138204657,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) delivered earnings and revenue surprises of +0.20% and -2.76%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=30efadb4b98eeeb4ea73139a9099c6d50c0cb7b1bd1146804e6b64b2ce3840e3"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Today’s Movers: Moderna, Intel, GameStop, Micron, Venture Global, and More",
    "summary": "Intel shares are climbing again ahead of the chip maker’s fourth-quarter earnings, due out after the close of trading Thursday.",
    "url": "https://finnhub.io/api/news?id=6fcb7cff84fed4d23fdde6841622958b046b07e4af7b353d81086b4ffa02edbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769082660,
      "headline": "These Stocks Are Today’s Movers: Moderna, Intel, GameStop, Micron, Venture Global, and More",
      "id": 138203095,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Intel shares are climbing again ahead of the chip maker’s fourth-quarter earnings, due out after the close of trading Thursday.",
      "url": "https://finnhub.io/api/news?id=6fcb7cff84fed4d23fdde6841622958b046b07e4af7b353d81086b4ffa02edbf"
    }
  },
  {
    "ts": null,
    "headline": "Earnings live: GE Aerospace orders surge, Procter & Gamble and Abbott stocks dip",
    "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
    "url": "https://finnhub.io/api/news?id=0dbc79d78237b39df48b4d83b5c739ecbf08903a9480e2ddda046a19d5163bf3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769087950,
      "headline": "Earnings live: GE Aerospace orders surge, Procter & Gamble and Abbott stocks dip",
      "id": 138203808,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, Procter & Gamble, and Intel.",
      "url": "https://finnhub.io/api/news?id=0dbc79d78237b39df48b4d83b5c739ecbf08903a9480e2ddda046a19d5163bf3"
    }
  },
  {
    "ts": null,
    "headline": "Abbott falls as fourth quarter revenue misses expectations",
    "summary": "Investing.com -- Abbott Laboratories (NYSE:ABT) reported fourth-quarter earnings that met expectations but missed on revenue, sending shares down 4.8% as investors reacted to the shortfall and weaker-than-expected first quarter guidance.",
    "url": "https://finnhub.io/api/news?id=85c773a37496e96e245ea51521ff9afb4d3b60c5f9965d482dd52abdde966a32",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769087744,
      "headline": "Abbott falls as fourth quarter revenue misses expectations",
      "id": 138203859,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Investing.com -- Abbott Laboratories (NYSE:ABT) reported fourth-quarter earnings that met expectations but missed on revenue, sending shares down 4.8% as investors reacted to the shortfall and weaker-than-expected first quarter guidance.",
      "url": "https://finnhub.io/api/news?id=85c773a37496e96e245ea51521ff9afb4d3b60c5f9965d482dd52abdde966a32"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Thursday: Intel, P&G, Volkswagen",
    "summary": "↗️ Intel (INTC): The chip company, in which the government has invested, is due to post earnings on Thursday afternoon. Shares were up around 1.5% in premarket trading, after surging 12% in Wednesday's regular session following an analyst upgrade.",
    "url": "https://finnhub.io/api/news?id=30dcba6a7ee605f4db735edbdff750407ad13f45f68cb5b617ad54870f803299",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769076456,
      "headline": "Stocks to Watch Thursday: Intel, P&G, Volkswagen",
      "id": 138203099,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "↗️ Intel (INTC): The chip company, in which the government has invested, is due to post earnings on Thursday afternoon. Shares were up around 1.5% in premarket trading, after surging 12% in Wednesday's regular session following an analyst upgrade.",
      "url": "https://finnhub.io/api/news?id=30dcba6a7ee605f4db735edbdff750407ad13f45f68cb5b617ad54870f803299"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT) Q4 2025 Earnings Call Transcript",
    "summary": "Abbott Laboratories (ABT) Q4 2025 Earnings Call January 22, 2026 9:00 AM ESTCompany ParticipantsMichael Comilla - Vice President of Investor...",
    "url": "https://finnhub.io/api/news?id=05bde06b87d464abb5b257e9f82c61b07377a96718e1783e561f837fab102790",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769086491,
      "headline": "Abbott Laboratories (ABT) Q4 2025 Earnings Call Transcript",
      "id": 138205764,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Abbott Laboratories (ABT) Q4 2025 Earnings Call January 22, 2026 9:00 AM ESTCompany ParticipantsMichael Comilla - Vice President of Investor...",
      "url": "https://finnhub.io/api/news?id=05bde06b87d464abb5b257e9f82c61b07377a96718e1783e561f837fab102790"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Stock Slumps on Earnings. What’s Weighing on the Medical Devices Maker.",
    "summary": "Shares of  Abbott Laboratories  tumbled Thursday after the medical devices maker posted fourth-quarter earnings and sales that underwhelmed Wall Street.  The company said it expects adjusted earnings in the range of $5.55 to $5.80 a share for the full year.  Abbott also is targeting full-year organic sales growth of between 6.5% to 7.5%.",
    "url": "https://finnhub.io/api/news?id=a78f416e3c4294f7c8ab50eba2681002cf58e296a2cf3b10ba52b4aabeb9fbfb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769086140,
      "headline": "Abbott Stock Slumps on Earnings. What’s Weighing on the Medical Devices Maker.",
      "id": 138203860,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Shares of  Abbott Laboratories  tumbled Thursday after the medical devices maker posted fourth-quarter earnings and sales that underwhelmed Wall Street.  The company said it expects adjusted earnings in the range of $5.55 to $5.80 a share for the full year.  Abbott also is targeting full-year organic sales growth of between 6.5% to 7.5%.",
      "url": "https://finnhub.io/api/news?id=a78f416e3c4294f7c8ab50eba2681002cf58e296a2cf3b10ba52b4aabeb9fbfb"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Misses Q4 CY2025 Revenue Estimates, Stock Drops",
    "summary": "Healthcare product and device company Abbott Laboratories (NYSE:ABT) fell short of the markets revenue expectations in Q4 CY2025 as sales rose 4.4% year on year to $11.46 billion. Its non-GAAP profit of $1.50 per share was in line with analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=2185ab8ebc95a8e695f20e0c3b65beacce2f5c38146fe1c745a0145f93c29cd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769085722,
      "headline": "Abbott Laboratories (NYSE:ABT) Misses Q4 CY2025 Revenue Estimates, Stock Drops",
      "id": 138203861,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Healthcare product and device company Abbott Laboratories (NYSE:ABT) fell short of the markets revenue expectations in Q4 CY2025 as sales rose 4.4% year on year to $11.46 billion. Its non-GAAP profit of $1.50 per share was in line with analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=2185ab8ebc95a8e695f20e0c3b65beacce2f5c38146fe1c745a0145f93c29cd5"
    }
  },
  {
    "ts": null,
    "headline": "Abbott misses quarterly revenue estimates on weakness in diagnostics, nutrition",
    "summary": "Jan 22 (Reuters) - Abbott missed Wall Street estimates for quarterly revenue on Thursday, hit by weakness in its diagnostic and nutrition business.",
    "url": "https://finnhub.io/api/news?id=31eb34c4c9ef6630f1bab1bee36d39a504c123e8f75ce3c2f2059f77ca16564e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769085502,
      "headline": "Abbott misses quarterly revenue estimates on weakness in diagnostics, nutrition",
      "id": 138203862,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Jan 22 (Reuters) - Abbott missed Wall Street estimates for quarterly revenue on Thursday, hit by weakness in its diagnostic and nutrition business.",
      "url": "https://finnhub.io/api/news?id=31eb34c4c9ef6630f1bab1bee36d39a504c123e8f75ce3c2f2059f77ca16564e"
    }
  },
  {
    "ts": null,
    "headline": "Abbott: Q4 Earnings Snapshot",
    "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was also for earnings of $1.50 per share. The maker of infant formula, medical devices and drugs posted revenue of $11.46 billion in the period, which fell short of Street forecasts. Nine analysts surveyed by Zacks expected $11.78 billion.",
    "url": "https://finnhub.io/api/news?id=881f3b4535323397583e32ca3b60709ff4b7124c56ccb3834a0359b30ff84bb2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769085459,
      "headline": "Abbott: Q4 Earnings Snapshot",
      "id": 138203863,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The average estimate of 10 analysts surveyed by Zacks Investment Research was also for earnings of $1.50 per share. The maker of infant formula, medical devices and drugs posted revenue of $11.46 billion in the period, which fell short of Street forecasts. Nine analysts surveyed by Zacks expected $11.78 billion.",
      "url": "https://finnhub.io/api/news?id=881f3b4535323397583e32ca3b60709ff4b7124c56ccb3834a0359b30ff84bb2"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Gain Pre-Bell Amid Trump's Greenland Tariff Reversal; Investors Await Inflation Data",
    "summary": "US equity markets were tracking higher in Thursday's premarket activity after President Donald Trump",
    "url": "https://finnhub.io/api/news?id=525058bd201e2e4ff9a412c5042ab10585c09c4147474f031fc884477a838d55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769085053,
      "headline": "Stocks Gain Pre-Bell Amid Trump's Greenland Tariff Reversal; Investors Await Inflation Data",
      "id": 138203819,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "US equity markets were tracking higher in Thursday's premarket activity after President Donald Trump",
      "url": "https://finnhub.io/api/news?id=525058bd201e2e4ff9a412c5042ab10585c09c4147474f031fc884477a838d55"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook",
    "summary": "Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2025.",
    "url": "https://finnhub.io/api/news?id=7a28165c1a8967b69cf86a5891bc14d2cccb65c6d18c3d63c9f9fee5acd78979",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769085000,
      "headline": "Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook",
      "id": 138203865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (NYSE: ABT) today announced financial results for the fourth quarter ended Dec. 31, 2025.",
      "url": "https://finnhub.io/api/news?id=7a28165c1a8967b69cf86a5891bc14d2cccb65c6d18c3d63c9f9fee5acd78979"
    }
  },
  {
    "ts": null,
    "headline": "Want Decades of Passive Income? 2 Stocks to Buy Right Now.",
    "summary": "Their dividend streaks speak volumes.",
    "url": "https://finnhub.io/api/news?id=68d659d0b9fca01d37339bc7c801be72c42ae2fc8c679415d8d7d7d0c0cbe542",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769078460,
      "headline": "Want Decades of Passive Income? 2 Stocks to Buy Right Now.",
      "id": 138203140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Their dividend streaks speak volumes.",
      "url": "https://finnhub.io/api/news?id=68d659d0b9fca01d37339bc7c801be72c42ae2fc8c679415d8d7d7d0c0cbe542"
    }
  },
  {
    "ts": null,
    "headline": "Cramer's Mad Dash: Abbott Labs",
    "summary": "CNBC’s Jim Cramer delivers his daily Mad Dash.",
    "url": "https://finnhub.io/api/news?id=4aa81e8a9a0bebc60d91e5e42431a722be75f99d7997d0109872ea90d28f3295",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769074740,
      "headline": "Cramer's Mad Dash: Abbott Labs",
      "id": 138205415,
      "image": "https://image.cnbcfm.com/api/v1/image/108255688-17690922871769092284-43627915881-1080pnbcnews.jpg?v=1769092286&w=1920&h=1080",
      "related": "ABT",
      "source": "CNBC",
      "summary": "CNBC’s Jim Cramer delivers his daily Mad Dash.",
      "url": "https://finnhub.io/api/news?id=4aa81e8a9a0bebc60d91e5e42431a722be75f99d7997d0109872ea90d28f3295"
    }
  },
  {
    "ts": null,
    "headline": "Musk at Davos, Intel Earnings, Inflation Gauge: Still to Come This Week",
    "summary": "Earnings season kicked up a gear this week, with results still due from Intel, among other companies. Plus, the World Economic Forum continues in Davos, Switzerland, and the Federal Reserve's preferred inflation gauge is due.",
    "url": "https://finnhub.io/api/news?id=df21b7fa3fedcba39c34321027f2096d3a47351c90b731d7456e00ccf7f50494",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769073185,
      "headline": "Musk at Davos, Intel Earnings, Inflation Gauge: Still to Come This Week",
      "id": 138203804,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Earnings season kicked up a gear this week, with results still due from Intel, among other companies. Plus, the World Economic Forum continues in Davos, Switzerland, and the Federal Reserve's preferred inflation gauge is due.",
      "url": "https://finnhub.io/api/news?id=df21b7fa3fedcba39c34321027f2096d3a47351c90b731d7456e00ccf7f50494"
    }
  },
  {
    "ts": null,
    "headline": "Davos, Intel Earnings, Inflation Data: Still to Come This Week",
    "summary": "Earnings season kicked up a gear this week, with results still due from Intel, among other companies. Plus, the World Economic Forum continues in Davos, Switzerland, and the Federal Reserve's preferred inflation gauge is due.",
    "url": "https://finnhub.io/api/news?id=53d9edf295df670e05eb123398d41789b21ee13ae15af5b29c56abb4e74bae64",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769073185,
      "headline": "Davos, Intel Earnings, Inflation Data: Still to Come This Week",
      "id": 138203116,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Earnings season kicked up a gear this week, with results still due from Intel, among other companies. Plus, the World Economic Forum continues in Davos, Switzerland, and the Federal Reserve's preferred inflation gauge is due.",
      "url": "https://finnhub.io/api/news?id=53d9edf295df670e05eb123398d41789b21ee13ae15af5b29c56abb4e74bae64"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”",
    "summary": "GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the stocks Jim Cramer recently looked at. Noting that they own 83 shares of GEHC, a caller asked if they should sell their position. In response, Cramer said: Okay, I worked for GE, so I got, I’m not allowed to own stock. I want to make that […]",
    "url": "https://finnhub.io/api/news?id=6beaecf919e178c56f5019ee823d2115323841ac1bb9cba9d0f1973e6af7352c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769069353,
      "headline": "Jim Cramer on GE HealthCare: “I Just Don’t Think It’s What You Want to Own”",
      "id": 138202446,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the stocks Jim Cramer recently looked at. Noting that they own 83 shares of GEHC, a caller asked if they should sell their position. In response, Cramer said: Okay, I worked for GE, so I got, I’m not allowed to own stock. I want to make that […]",
      "url": "https://finnhub.io/api/news?id=6beaecf919e178c56f5019ee823d2115323841ac1bb9cba9d0f1973e6af7352c"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves premarket: Procter & Gamble, Mobileye, McCormick, GameStop & more",
    "summary": "These are the stocks posting the largest moves in the premarket.",
    "url": "https://finnhub.io/api/news?id=2e28935750d6ca3c3577701acb99ba48fa5f5f98ea947d4687ea18386a10f682",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769067623,
      "headline": "Stocks making the biggest moves premarket: Procter & Gamble, Mobileye, McCormick, GameStop & more",
      "id": 138205346,
      "image": "https://image.cnbcfm.com/api/v1/image/108177260-1753465600549-gettyimages-2224899181-250712_costco_brands_111.jpeg?v=1765989026&w=1920&h=1080",
      "related": "ABT",
      "source": "CNBC",
      "summary": "These are the stocks posting the largest moves in the premarket.",
      "url": "https://finnhub.io/api/news?id=2e28935750d6ca3c3577701acb99ba48fa5f5f98ea947d4687ea18386a10f682"
    }
  }
]